PerkinRA (Anakinra PFS) 100mg/0.67ml

PerkinRA Anakinra 100mg/0.67ml PFS is an interleukin-1 receptor antagonist used for inflammatory conditions. Store between 2-8°C and protect from light. This biologic therapy helps manage symptoms in autoimmune disorders. Suitable for adults and children with approved indications.

Strength

100mg/0.67ml

Pack Size

28s

Storage

2-8°

Manufacturer / TM Owner

PersisGen Par Co

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PerkinRA Anakinra 100mg/0.67ml PFS is used to treat rheumatoid arthritis, Still’s disease, and other inflammatory disorders. It helps reduce joint pain and swelling by blocking interleukin-1, a key inflammatory protein. This medication is prescribed when other treatments have not been effective. It is also used in certain rare autoinflammatory conditions.

Side Effects

PerkinRA Anakinra 100mg/0.67ml PFS may help reduce pain, swelling, and stiffness in affected joints. Some users report improved mobility and daily function over time. Injection-site reactions like redness or swelling are common but usually mild. Regular use as prescribed can lead to gradual symptom improvement.

Precautions & Warnings

Keep PerkinRA Anakinra 100mg/0.67ml PFS refrigerated between 2-8°C and avoid freezing. Protect from light by storing in the original carton. Do not use if the solution is cloudy or contains particles. Always check the expiration date before use. Dispose of used syringes properly in a sharps container.

Avoid Interactions

PerkinRA Anakinra may interact with other biologics or immunosuppressants, increasing infection risk. Avoid live vaccines while using this medication. Some drugs, like tumor necrosis factor inhibitors, may reduce its effectiveness. Always inform your healthcare provider about all medications you are taking. Alcohol use may worsen certain side effects.

Frequently Asked Questions

It is used to treat inflammatory conditions like rheumatoid arthritis and Still’s disease by blocking interleukin-1.

Store between 2-8°C in the original carton and protect from light.

Consult your healthcare provider before combining with other drugs, especially biologics or immunosuppressants.

Common effects include injection-site reactions like redness or swelling.

It is approved for certain pediatric inflammatory conditions; consult a doctor for suitability.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.